Overview

Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A 2-night polysomnography / 5-way cross-over study to evaluate the effect, safety and tolerability of oral administration of almorexant (ACT 078573) in elderly subjects with primary insomnia.
Phase:
Phase 2
Details
Lead Sponsor:
Midnight Pharma, LLC